Inactive Instrument
Isodiol International Inc Stock Canadian Securities Exchange
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded
| Market Cap | 3.91M 2.8M 2.41M 2.22M 2.08M 264M 3.95M 26.22M 10.21M 129M 10.49M 10.27M 449M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.53M 5.63M 5.18M 4.86M 617M 9.23M 61.22M 23.85M 302M 24.5M 23.98M 1.05B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -3.58% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.58% | +881.08% | - | - | 128 | |
| -1.48% | -0.02% | -11.56% | -7.40% | 13.04B | |
| -1.85% | -0.53% | -32.96% | -56.25% | 4.94B | |
| -2.20% | -2.26% | -9.39% | -2.24% | 4.56B | |
| -1.39% | +1.27% | +14.39% | -15.33% | 3.83B | |
| -5.15% | -0.98% | +5.00% | -43.45% | 3.73B | |
| -1.41% | -3.28% | -4.08% | -8.97% | 3.62B | |
| -2.20% | +1.14% | -10.12% | -2.67% | 3.14B | |
| +0.39% | +6.56% | -4.94% | -24.93% | 2.43B | |
| -1.48% | -4.08% | -12.67% | +33.53% | 1.72B | |
| Average | -2.03% | -1.29% | -7.37% | -14.19% | 4.56B | |
| Weighted average by Cap. | -1.87% | -1.38% | -8.85% | -15.83% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.68M 11.79M 10.86M 10.19M 1.29B 19.34M 128M 49.98M 633M 51.34M 50.25M 2.19B | 22.25M 15.9M 13.71M 12.62M 11.85M 1.5B 22.48M 149M 58.1M 736M 59.69M 58.42M 2.55B |
| Net income | -36.02M -25.75M -22.19M -20.43M -19.19M -2.43B -36.4M -241M -94.07M -1.19B -96.63M -94.58M -4.13B | -126M -90.01M -77.57M -71.43M -67.06M -8.51B -127M -844M -329M -4.17B -338M -331M -14.44B |
| Net Debt | -15.55M -11.12M -9.58M -8.82M -8.28M -1.05B -15.71M -104M -40.61M -515M -41.71M -40.83M -1.78B | 5.22M 3.73M 3.22M 2.96M 2.78M 353M 5.28M 35.01M 13.64M 173M 14.01M 13.71M 599M |
Employees
-
Sector
Pharmaceuticals
